JEAN LE GALL: Open Payments
NPI 1982857579 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$697 in 26 payments from 12 companies in 2025. Trend: 2023 $1,336 · 2024 $566 · 2025 $697
Food & beverage: $697
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $215 |
| PFIZER INC. | 1 | $98 |
| AstraZeneca Pharmaceuticals LP | 1 | $94 |
| Novo Nordisk Inc | 3 | $72 |
| Axsome Therapeutics, Inc. | 2 | $51 |
| Astellas Pharma US Inc | 2 | $40 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
| Philips North America LLC | 1 | $25 |
| Lundbeck LLC | 1 | $18 |
| Amgen Inc. | 1 | $17 |
Products named: QULIPTA, ZAVZPRET, AIRSUPRA, Veozah, CAPLYTA, Symbravo, VRAYLAR, MCOT.
Industry payments across FL — which companies pay providers there.
